Australia's Proteomics International Laboratories slumps on terminating US licensing deal

Proteomics International Laboratories

11/09/2024 01:53

** Shares of Proteomics International Laboratories  PIQ.AX 
fall as much as 19.5% to A$0.700, their lowest since Aug. 17,
2023
    ** Stock posts its biggest intraday percentage decline since
March 18
    ** Medical technology co says it has terminated its
agreement with Sonic Healthcare USA for the use and
commercialisation of its predictive test for diabetic kidney
disease in the U.S.
    ** About 727,000 shares change hands, compared with the
30-day average volume of around 148,000
    ** Stock down 14% YTD, including session's move



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))